Optibrium demonstrates accelerated lead optimisation in complex agrochemical development
Optibrium’s QuanSA 3D-QSAR method uses an active learning approach to successfully and more efficiently identify a mimic of a macrocyclic natural product
Cellular Origins acquires ACTIA Platform IP to enhance automated cell therapy manufacturing
Autologous Cell Therapy Industrial Automation (ACTIA) strengthens technology and IP portfolio of Cellular Origins supporting ongoing development and expanding capabilities of Constellation platform
Bio-Rad launches ChemiDoc Go Imaging System
Compact system uses CMOS Digital Imaging and is compatible with chemiluminescence and fluorescence detection and stain-free technologyHERCULES, Calif.
Pulmonary fibrosis: challenges in diagnosis, treatment and management
Pulmonary fibrosis (PF) is a progressive lung disease characterised by fibrosis or scarring of the lung tissue. As the disease progresses the build-up of fibrotic tissue causes the lungs to stiffen, limiting their ability to expand and contract, resulting in declines in lung function.
Are you going through a career slump?
If you were to score out of 10 how excited and motivated you feel about your work (and career) what number would you give it? If you score it 8, 9 or 10, give yourself a big pat on the back - you are really fortunate! If you give it a 6 -7 out of 10, there is room for improvement... Anything less than 6 needs serious action!
Transforming Healthcare Podcast: bridging industry and academia for innovation
In this episode host Dr.
Bio-Rad launches Celselect Slides 2.0 to advance rare cell and circulating tumor cell enrichment for cancer research
New Celselect Slides™ Design Increases Efficiency of Circulating Tumor Cell Capture from Liquid Biopsy Samples for Enumeration and Downstream ApplicationsHercules Calif. — Bio-Rad Laboratories, Inc.
CN Bio appoints Lydia Seymour as VP People and Culture to further strengthen leadership team
Key appointment to support continued UK and US team expansionCambridge, UK, 27: CN Bio, a leading provider of single- and multi-organ microphysiological systems, announces the appointment of Lydia Seymour as Vice President of People and Cultur
ELRIG UK and The Protein Society partner to advance protein sciences in drug discovery
Cambridge, UK and Los Angeles, US: The European Laboratory Research & Innovation Group (ELRIG) UK, a not-for-profit, volunteer-led organisation for the drug discovery community, has partnered with The Protein Society (TPS), an international, not-for-profit, scholarly society,
ASCO 2024 review: The benefits and barriers of biomarkers in oncology
Once again, Chicago saw the gathering of oncologists to discuss the latest developments in cancer. This year, considerable emphasis was placed on antibody-drug conjugates (ADCs), with several sessions dedicated exclusively to this technology.
Sapio Sciences introduces Sapio GMP LIMS offering unmatched flexibility for unique manufacturing processes
Sapio Sciences announces key new capabilities to its highly flexible, no/low-code LIMS to support laboratories that must comply with GMP, 21 CFR 11, and EU Annex 11 standardsBaltimore, MD: Sapio Sciences
Primerdesign launches real-time PCR workflow for onsite detection of Norovirus in Oysters
genesig Easy_oys Detection Kit offers rapid and reliable qPCR workflow to quantify Norovirus GI and GII pathogens in oyster tissue Onsite analysis helps ensure shellfish quality and safety across the production line, reducing public health risk DeBio-Rad extends range of anti-biotherapeutic antibodies to accelerate antibody drug development
Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical TrialsHercules, Calif - Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products
mRNA influenza vaccines – VacZine Analytics forecast a third of global market value in 2030
This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global analysis of the seasonal influenza vaccine market including mRNA products (monovalent and combinations)
Bio-Rad launches ddSEQ™ Single-Cell 3' RNA-Seq Kit for Single-Cell Gene Expression
ddSEQ™ Single-Cell 3' RNA-Seq Kit and Omnition v1.1 Analysis Software Enable High-Quality and Affordable Single-Cell Transcription and Gene Expression to Support Molecular Biology, Oncology, and Drug Discovery Research.
Uptake of advanced therapies in psoriasis and psoriatic arthritis
he uptake of innovative advanced treatments in immunology is highly dependent on the indication, with new innovative treatments gaining market share quickly in psoriasis, while older entrenched products still hold considerable market share in psoriatic arthritis.
Exploring the complexities of Pulmonary Hypertension
Pulmonary hypertension (PH) is a serious condition characterised by elevated blood pressure within the pulmonary arteries. The pulmonary arteries are responsible for carrying blood from the right-hand side of the heart to the lungs.
Milner Therapeutics Institute Director Professor Tony Kouzarides awarded a knighthood in King's Birthday Honours List
Professor Tony Kouzarides, Director of the Milner Therapeutics Institute, has been awarded a knighthood for services to healthcare innovation and delivery.
Gyros Protein Technologies introduces Gyrolab Generic Anti-AAV Kit to support gene therapy development
Ready-to-use kit enables detection of binding antibodies against AAV vectors without the need for serotype-specific assays
Animating the science of a firearm - WaveFX
WaveFX writes...our talented CG artists can bring any process to life, for example this STEM based client wanted to show the firing process of a firearm as part of a series of educational videos.
Price Bailey encourages Cambridge based healthcare businesses looking to sell, to act now
With the general election announced for July, Price Bailey is urging healthcare businesses to sell up now to avoid potential post-election tax hikes.
Enterprise Therapeutics appoints Dr Renu Gupta as Chief Medical Officer and Dr Janet Hammond as Non-Executive Director
Brighton, UK: Enterprise Therapeutics Ltd (Enterprise), a biopharmaceutical company dedicated to the discovery and development of novel therapies to improve the lives of patients suffering from respiratory disease, announces the appointment of Dr Renu Gupta as CMO (Chief Medical
Sphere Fluidics awarded Gold accreditation by Investors in People
Internationally-recognized ‘We invest in people’ award is certified recognition of the Company’s care and commitment to its employees globally